Cargando…

Oncology professionals’ perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study

Breast cancer (BC) patients have an increased risk of developing cancer therapy-related cardiac dysfunction (CTRCD) and cardiovascular morbidity, which seems to have a substantial prognostic impact. Oncologists, in collaboration with dedicated cardiologists, have the opportunity to perform cardiovas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koop, Yvonne, Dobbe, Laura, Maas, Angela H. E. M., van Spronsen, Dick Johan, Atsma, Femke, El Messaoudi, Saloua, Vermeulen, Hester
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011722/ https://www.ncbi.nlm.nih.gov/pubmed/33788897 http://dx.doi.org/10.1371/journal.pone.0249067

Ejemplares similares

Healthcare utilization and hospital variation in cardiac surveillance during breast cancer treatment: a nationwide prospective study in 5000 Dutch breast cancer patients
por: Koop, Yvonne, et al.
Publicado: (2020)

Future steps in cardio-oncology—a national multidisciplinary survey among healthcare professionals in the Netherlands
por: Koop, Yvonne, et al.
Publicado: (2022)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010)

Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy
por: Han, Xinqiang, et al.
Publicado: (2017)

Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care
por: Cheng, Richard K., et al.
Publicado: (2019)

Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology
por: Simek, Shawn, et al.
Publicado: (2022)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies: Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology
por: Bergler-Klein, Jutta, et al.
Publicado: (2022)

Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2019)

Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
por: Ohman, Rachel E., et al.
Publicado: (2021)

Eight-year experience of maternal death surveillance in Morocco: qualitative study of stakeholders’ views at a subnational level
por: Abouchadi, Saloua, et al.
Publicado: (2022)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
por: Yu, Anthony F., et al.
Publicado: (2020)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Cardiotoxicity of anthracycline-free targeted oncological therapies in HER2-positive breast cancer
por: Guan, Jingyuan, et al.
Publicado: (2021)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Understanding unwarranted variation in clinical practice: a focus on network effects, reflective medicine and learning health systems
por: Atsma, Femke, et al.
Publicado: (2020)

Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional’s perspective
por: Graupner, Caitlin, et al.
Publicado: (2021)

Healthcare Professionals' Culture Toward Reporting Errors in the Oncology Setting
por: Bany Hamdan, Abdullah, et al.
Publicado: (2023)

Essential Oncology for Health Professionals
por: Pandha, Hardev, et al.
Publicado: (1995)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
por: Kang, Dong-Woo, et al.
Publicado: (2022)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification
por: Bergom, Carmen, et al.
Publicado: (2021)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

The impact of COVID-19 on cancer patients, their carers and oncology health professionals: A qualitative study
por: Butow, P., et al.
Publicado: (2022)

Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study
por: Geuijen, Pauline, et al.
Publicado: (2023)

Perspectives of professionals participating in the Brazilian Network for the Surveillance of Severe Maternal Morbidity regarding the implementation of routine surveillance: a qualitative study
por: Luz, Adriana Gomes, et al.
Publicado: (2014)

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs
por: Wen, Hai-ni, et al.
Publicado: (2022)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

The pediatric oncology exercise field speeds up to address important issues regarding chemotherapy-related cardiotoxicity
por: Caru, Maxime, et al.
Publicado: (2022)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
por: Zito, Concetta, et al.
Publicado: (2022)

The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity
por: Leo, Isabella, et al.
Publicado: (2023)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Emphasising Organisational Routine: A Qualitative Study of Patient and Health Professional Experiences of Inpatient Oncology Care
por: Watermeyer, Jennifer, et al.
Publicado: (2022)

Clinical practice guideline recommendation summaries for pediatric oncology health care professionals: A qualitative study
por: Santesso, Nancy, et al.
Publicado: (2023)

What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence
por: Nic Giolla Easpaig, Bróna, et al.
Publicado: (2020)

Defining a positive work environment for hospital healthcare professionals: A Delphi study
por: Maassen, Susanne M., et al.
Publicado: (2021)

728 A Survey of Health Professionals' Attitudes Regarding Substance Abuse Disorder in Burn Patients
por: Richey, Karen, et al.
Publicado: (2023)

How do treatment aims in the last phase of life relate to hospitalizations and hospital mortality? A mortality follow-back study of Dutch patients with five types of cancer
por: Oosterveld-Vlug, Mariska, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lrikl701e9054tgjur573rbj3j